Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX)

Historical Holders from Q3 2023 to Q4 2025

Type / Class
Equity / Ordinary Shares, $0.0001 par value
Symbol
AKTX on Nasdaq
Shares outstanding
53,512,954,839
Price per share
$0.29
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,170,067
Total reported value
$1,181,319
% of total 13F portfolios
0%
Share change
+619,327
Value change
+$593,370
Number of holders
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Huh Hoyoung 16% $9,206,903,880 8,294,508,000 Hoyoung Huh, M.D., Ph.D. 14 Nov 2024
Prudo-Chlebosz Raymond 9.3% $5,468,526,888 4,926,600,800 Ray Prudo, M.D. 14 Nov 2024
As of 30 Sep 2025, Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) has 16 institutional shareholders filing 13F forms. They hold 1,170,067 shares. of 53,512,954,839 outstanding shares (0%) .

Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 55,000 $15,895 +$15,895 $0.29 1
2025 Q3 1,170,067 $1,181,319 +$593,370 $1.01 16
2025 Q2 550,740 $644,311 +$288,311 $1.17 15
2025 Q1 304,298 $377,330 -$22,653 $1.24 10
2024 Q4 322,783 $393,794 +$114,040 $1.22 14
2024 Q3 181,321 $535,895 +$11,085 $2.95 10
2024 Q2 180,188 $488,063 +$56,787 $2.70 10
2024 Q1 174,737 $326,340 +$98,946 $1.86 7
2023 Q4 121,755 $379,836 -$22,784 $3.12 7
2023 Q3 123,042 $486,015 +$486,017 $3.95 7